Akero Therapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Akero Therapeutics, Inc. reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $2.55 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2025-02-28
- Akero Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $2.55M, a 140.15% increase from fiscal 2023.
- Akero Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $1.06M, a 42.23% increase from fiscal 2022.
- Akero Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $746.00K, a 23.71% increase from fiscal 2021.
- Akero Therapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2021 was $603.00K, a 48.16% increase from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $2.55M 10-K · filed 2025-02-28 |
| 2023-12-31 | $1.06M 10-K · filed 2025-02-28 |
| 2022-12-31 | $746.00K 10-K · filed 2025-02-28 |
| 2021-12-31 | $603.00K 10-K · filed 2024-02-29 |
| 2020-12-31 | $407.00K 10-K · filed 2022-02-25 |
| 2019-12-31 | $237.00K 10-K · filed 2022-02-25 |